XT
NNVC icon

XTX Topco’s NanoViricides NNVC Stock Holding History

XTX Topco’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,432
Closed -$32.3K – 4530
2026
Q1 		$32.3K Buy
35,432
+16,546
+88% +$17.3K ﹤0.01% 3435
2025
Q4 		$21.3K Buy
18,886
+8,110
+75% +$11.4K ﹤0.01% 3045
2025
Q3 		$15.4K Sell
10,776
-10,367
-49% -$15.5K ﹤0.01% 2372
2025
Q2 		$29.6K Sell
21,143
-30,109
-59% -$41.1K ﹤0.01% 2113
2025
Q1 		$60K Buy
+51,252
New +$65K ﹤0.01% 1965
2023
Q4 		– Sell
-10,214
Closed -$13.7K – 1940
2023
Q3 		$13.7K Buy
+10,214
New +$14.4K ﹤0.01% 1407

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

XTX Topco's NNVC Position: Q2 2026 in Review

XTX Topco sold out of NanoViricides (NNVC) in Q2 2026, closing a stake of 35,432 shares — an estimated $32.3K sold.

XTX Topco first reported a position in NNVC in Q3 2023 and held it in 6 quarters. The position peaked at $60K in Q1 2025. 47 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • XTX Topco reported no remaining NanoViricides position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 35,432 NanoViricides shares in Q2 2026, an estimated $32.3K.
  • XTX Topco first reported a position in NanoViricides in Q3 2023 and held it in 6 quarters.
  • XTX Topco's NanoViricides position peaked at $60K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.